Skip to Content Skip to Content

Medicine

Reset All Filters
1641 Results
Alzheimer’s drug trials target older Californians. Do they understand what they’re signing up for?

Alzheimer’s drug trials target older Californians. Do they understand what they’re signing up for?

Emily Largent of the Perelman School of Medicine supports the FDA’s recommendations that scientists running drug studies consider having an independent monitor such as a clinician unaffiliated with the trial’s sponsor oversee consent procedures. 

In Philly and nationwide, interest is rising in psychedelics to treat depression. The FDA released new research guidelines

In Philly and nationwide, interest is rising in psychedelics to treat depression. The FDA released new research guidelines

Holly Fernandez Lynch of the Perelman School of Medicine is quoted on the unique challenges of designing effective studies with psychedelic drugs, including participants knowing if they've been given a placebo or not.

Katalin Susztak hunts for a cure for kidney disease
Katalin Susztak

Katalin Susztak, professor of internal medicine, nephrology, and genetics at the Perelman School of Medicine.

(Image: Penn Medicine News)

Katalin Susztak hunts for a cure for kidney disease

Throughout her career, the professor of internal medicine, nephrology, and genetics has had a profound impact on the way kidney disease is identified, prevented, and managed.

From Penn Medicine News

Antibody treatment prevents graft versus host disease in advanced preclinical tests
microscopic view of bone marrow

(Image: Courtesy of Penn Medicine News)

Antibody treatment prevents graft versus host disease in advanced preclinical tests

Penn Medicine, Dana-Farber Cancer Institute, and Boston Children’s Hospital research finds single antibody treatment blocked donor T-cell attack and increased survival rates in preclinical models.

From Penn Medicine News